I’ll never forget the first time I played a full round of golf.

I wasn’t half bad off the tee, but my short game was a disaster. I’d hit a clean drive, only to chunk my approach shot into a bunker, duff a chip, and three-putt my way to a double bogey.

Frustrating? Absolutely.

But an old man once told me: “Focus on the long game. If you get that right, the short game will follow.”

That lesson didn’t just apply to golf — it’s a perfect mindset for trading, especially when a stock looks beaten down but has the fundamentals and momentum to make a strong comeback.

And right now, Elevance Health (ELV) is showing all the signs of a market player taking a patient, strategic approach to victory.

---

Profit with our #1 Strategy!

Whether you’re looking for consistent triple-digit gains, expert insights, or top stock picks based on our Options Activity Scanner, you can find it all in one place:

AlphaX Options. This is your one-stop shop when it comes to market-beating analysis.

To learn more about AlphaX Options, click here.

---

Who is Elevance Health (ELV)?

Formerly known as Anthem, Elevance Health is a powerhouse in the healthcare sector, providing medical insurance and health solutions across the U.S. 

With its Blue Cross Blue Shield affiliation, ELV dominates in multiple states, offering everything from commercial health plans to Medicare and Medicaid services.

Healthcare stocks like ELV are often considered defensive plays — strong businesses that hold up even when the economy faces headwinds. 

But looking at ELV’s price action, you wouldn’t think that’s the case.

ELV’s Chart: A Stock That’s Been Stuck in the Rough

Take a look at the daily chart of ELV. 

After peaking above $550 last year, the stock tumbled hard, dropping below $350 in a major downtrend. 

But recently, something interesting has happened. It’s showing signs of life. A bottom has formed, and buyers are stepping back in.

The stock just popped above $400, and while it’s not a straight shot to recovery, this is exactly the kind of setup that big-money traders love to attack early—before the rest of the market catches on.

Spotting the Smart Money on ELV

Speaking of big-money traders, let’s talk about the elephant in the room:

🚨 Someone just dropped a $10.4 MILLION bet on ELV calls. 🚨

That’s right, this wasn’t just any trade. It was a block trade, meaning an institutional player executed it all at once, without splitting it into smaller retail-sized orders. That’s a serious sign of conviction.

The trade? 1,258 contracts of the ELV 420 calls expiring in January 2027, bought for $82.50 per contract.

This trader isn’t looking for a quick scalp. They’re not playing for tomorrow or next week. They’re positioning for a long-term recovery in ELV — exactly like a golfer who focuses on the long game, knowing the short-term struggles will smooth out over time.

What This Means for Traders Like Us

When you see a trade of this size, you have to ask yourself:

1️⃣ Why would someone put down $10.4 million unless they had serious confidence in ELV’s future?
2️⃣ What do they know that the average trader might not be paying attention to?
3️⃣ How can I align my trades with this kind of smart money flow?

It’s clear that someone is betting on ELV to rebound big over the next two years. Whether it’s improving earnings, positive legislative tailwinds, or just a technical reversal, they see value in getting positioned now—while the stock is still down.

Final Thoughts: Patience Pays Off

Back to that golf lesson… I never became a pro, but once I stopped stressing over my short-game mistakes and focused on consistent, controlled long shots, my scores improved.

The same applies to the market. Elevance Health has been in the rough, but someone just made a major play on its long-term recovery.

The question is, will you be ready to take the shot?

Trade Smart,

S.E.A.L. Alpha Team